Identification of peptide-mediated interactions between human PTTG and SH3 domains in pALL gene expression profile

Area of Science:

• Molecular Biology
• Oncology
• Bioinformatics

Background:

• The human pituitary tumor-transforming gene (PTTG) is implicated in the development and progression of pediatric acute lymphoblastic leukemia (pALL).
• PTTG possesses two SH3-binding peptide motifs that mediate interactions with SH3-containing proteins within pALL cells.

Purpose of the Study:

• To identify potential protein partners of human PTTG in pALL.
• To investigate the binding affinity and selectivity of PTTG interactions with SH3 domains in pALL.

Main Methods:

• Integration of computational modeling and experimental assays to analyze pALL gene expression profiles.
• Knowledge-based scoring and fluorescence titration to rank the binding potency of SH3 domain candidates to PTTG peptide motifs.
• Rational mutation of PTTG peptides to target identified SH3 domain partner proteins.

Main Results:

• Identification of multiple SH3 domains from various pALL proteins as potent binders to PTTG with moderate to high affinity.
• Demonstration that PTTG peptide motifs exhibit differential affinity profiles for candidate proteins, suggesting optimized selectivity within the pALL gene expression landscape.
• Successful rational mutation of PTTG peptides to compete with native motifs for binding to identified partner SH3 domains.

Conclusions:

• PTTG interacts with a specific set of SH3-domain-containing proteins in pALL.
• The identified interactions and their selectivity offer potential therapeutic targets for pALL treatment.
• Targeting PTTG-protein interactions through peptide-based strategies may represent a novel therapeutic approach for pALL.